APOE and early-onset autosomal dominant Alzheimer disease: CSN3 can inhibit ABCA1 degradation by binding to it, while substances such as cadmium, AGEs, and APOE4 differentially regulate ABCA1 stability by affecting ubiquitination or lysosomal function, thereby being associated with pathological processes such as atherosclerosis and Alzheimer’s disease (AD).